These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 32618153)

  • 1. Sprouty 4 suppresses glioblastoma invasion by inhibiting ERK phosphorylation and ETS-1-induced matrix metalloproteinase-9.
    Zhao B; Sun J; DU K; Liang N; Sun J
    J Neurosurg Sci; 2023 Feb; 67(1):121-128. PubMed ID: 32618153
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sprouty4 correlates with favorable prognosis in perihilar cholangiocarcinoma by blocking the FGFR-ERK signaling pathway and arresting the cell cycle.
    Qiu B; Chen T; Sun R; Liu Z; Zhang X; Li Z; Xu Y; Zhang Z
    EBioMedicine; 2019 Dec; 50():166-177. PubMed ID: 31761616
    [TBL] [Abstract][Full Text] [Related]  

  • 3. TRAF6 correlated to invasion and poor prognosis of glioblastoma via elevating MMP9 expression.
    Sun J; Zhao B; Du K; Liu P
    Neuroreport; 2019 Jan; 30(2):127-133. PubMed ID: 30571666
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High Mobility Group Box 1 (HMGB1) Predicts Invasion and Poor Prognosis of Glioblastoma Multiforme via Activating AKT Signaling in an Autocrine Pathway.
    Cheng P; Ma Y; Gao Z; Duan L
    Med Sci Monit; 2018 Dec; 24():8916-8924. PubMed ID: 30531692
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lower Expression of SPRY4 Predicts a Poor Prognosis and Regulates Cell Proliferation in Colorectal Cancer.
    Zhou X; Xie S; Yuan C; Jiang L; Huang X; Li L; Chen Y; Luo L; Zhang J; Wang D; Liu L; Shi W; Han L; Tang N; Ji Y
    Cell Physiol Biochem; 2016; 40(6):1433-1442. PubMed ID: 27997895
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparative Analysis of Matrix Metalloproteinase Family Members Reveals That MMP9 Predicts Survival and Response to Temozolomide in Patients with Primary Glioblastoma.
    Li Q; Chen B; Cai J; Sun Y; Wang G; Li Y; Li R; Feng Y; Han B; Li J; Tian Y; Yi L; Jiang C
    PLoS One; 2016; 11(3):e0151815. PubMed ID: 27022952
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sprouty3 and Sprouty4, Two Members of a Family Known to Inhibit FGF-Mediated Signaling, Exert Opposing Roles on Proliferation and Migration of Glioblastoma-Derived Cells.
    Celik-Selvi BE; Stütz A; Mayer CE; Salhi J; Siegwart G; Sutterlüty H
    Cells; 2019 Aug; 8(8):. PubMed ID: 31374860
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High Expression of PTPN3 Predicts Progression and Unfavorable Prognosis of Glioblastoma.
    Wang Y; Su Y; Ji Z; Lv Z
    Med Sci Monit; 2018 Oct; 24():7556-7562. PubMed ID: 30348936
    [TBL] [Abstract][Full Text] [Related]  

  • 9. STAT6 expression in glioblastoma promotes invasive growth.
    Merk BC; Owens JL; Lopes MB; Silva CM; Hussaini IM
    BMC Cancer; 2011 May; 11():184. PubMed ID: 21595984
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interleukin-17 receptor D is a favorable biomarker of glioblastoma.
    Liu Y; Xie M; Zhou Y; Che L; Zhang B
    J Neurosurg Sci; 2024 Jun; 68(3):320-326. PubMed ID: 35380198
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MTHFD2 suppresses glioblastoma progression via the inhibition of ERK1/2 phosphorylation.
    Huang M; Xue J; Chen Z; Zhou X; Chen M; Sun J; Xu Z; Wang S; Xu H; Du Z; Liu M
    Biochem Cell Biol; 2023 Feb; 101(1):112-124. PubMed ID: 36493392
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of glycosyltransferase PomGnT1 in glioblastoma progression.
    Lan J; Guo P; Lin Y; Mao Q; Guo L; Ge J; Li X; Jiang J; Lin X; Qiu Y
    Neuro Oncol; 2015 Feb; 17(2):211-22. PubMed ID: 25085363
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mir-758-5p Suppresses Glioblastoma Proliferation, Migration and Invasion by Targeting ZBTB20.
    Liu J; Jiang J; Hui X; Wang W; Fang D; Ding L
    Cell Physiol Biochem; 2018; 48(5):2074-2083. PubMed ID: 30099442
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Up-Regulated Expression of SPRY4-IT1 Predicts Poor Prognosis in Colorectal Cancer.
    Tan W; Song ZZ; Xu Q; Qu X; Li Z; Wang Y; Yu Q; Wang S
    Med Sci Monit; 2017 Jan; 23():309-314. PubMed ID: 28099409
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High expression of long non-coding RNA SPRY4-IT1 predicts poor prognosis of clear cell renal cell carcinoma.
    Zhang HM; Yang FQ; Yan Y; Che JP; Zheng JH
    Int J Clin Exp Pathol; 2014; 7(9):5801-9. PubMed ID: 25337221
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression and clinical significance of organic cation transporter family in glioblastoma multiforme.
    Lian Q; Xiao S; Wang Y; Wang H; Xie D
    Ir J Med Sci; 2022 Jun; 191(3):1115-1121. PubMed ID: 34080124
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sprouty 2 protein, but not Sprouty 4, is an independent prognostic biomarker for human epithelial ovarian cancer.
    Masoumi-Moghaddam S; Amini A; Wei AQ; Robertson G; Morris DL
    Int J Cancer; 2015 Aug; 137(3):560-70. PubMed ID: 25630587
    [TBL] [Abstract][Full Text] [Related]  

  • 18. miR-144-3p serves as a tumor suppressor by targeting FZD7 and predicts the prognosis of human glioblastoma.
    Cheng ZX; Song YX; Wang ZY; Wang Y; Dong Y
    Eur Rev Med Pharmacol Sci; 2017 Sep; 21(18):4079-4086. PubMed ID: 29028093
    [TBL] [Abstract][Full Text] [Related]  

  • 19. PDRG1 promotes the proliferation and migration of GBM cells by the MEK/ERK/CD44 pathway.
    Sun J; Xu Y; Liu J; Cui H; Cao H; Ren J
    Cancer Sci; 2022 Feb; 113(2):500-516. PubMed ID: 34812552
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Early growth response 1 promoted the invasion of glioblastoma multiforme by elevating HMGB1.
    DU K; Wu X; Ji X; Liang N; Li Z
    J Neurosurg Sci; 2023 Aug; 67(4):422-430. PubMed ID: 33297605
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.